Cannabis companies in Nevada urged for changes to their state’s adult-use and medical cannabis programs which were acknowledged through several passed legislations.
In Nevada, cannabis companies lobbied for changes to be made regarding the state’s adult-use and medical cannabis programs. The recent legislative session answered their calls when they approved various bills which would benefit the cannabis industry (1).
The new pieces of legislation were signed into law in June 2023, by Governor Joe Lombardo. Among the newly enacted laws were reassessing penalties for operating violations, eliminating and capping various fees, and creating a dual license to be used by retailers serving both recreational consumers and medical patients. The bills shared bipartisan support in the state’s Democrat-controlled Legislature.
Industry insiders shared with MJBizDaily (1), that the policy changes will aid operators in saving tens of thousands of dollars per year in business expenses while also expanding their retail access.
“As the legal cannabis industry continues to evolve and look for ways to better serve consumers with safe and affordable products, we are grateful that our state legislators and Gov. Lombardo responded with a slate of supportive legislation,” said Scot Rutledge, a partner at Argentum Partners, a government affairs and marketing firm based in Reno (1).
With these latest developments, hopefully they will help Nevada’s cannabis sales which were down from their original peaks seen in 2021 (1). Cannabis companies are also eager and looking forward to the introduction of consumption lounges, mainly located within Las Vegas.
When Senate Bill 195 (SB 195) passed it allowed cannabis operators a break from the overwhelming fees and other costs needed for compliance.
According to MJBizDaily, key takaways from the bill were (1):
“If you look at some of the complaints in Nevada, you will see that they were most often in the six figures,” Layke Martin, executive director of the Nevada Cannabis Association said (1). “Many of the times, they were for administrative violations.”
Under Senate Bill 277 (SB 277), it implemented new benefits for retailers, consumers, and the supply chain in the state of Nevada, as well as, reduced the maximum fees for almost every cannabis license (3). There was some resistance within the industry.
“The result was that the fees for initial licensing and renewal of an adult-use cannabis license were reduced, except for the initial issuance of an adult-use retail license, which remains unchanged at $20,000,” Melissa Waite, an attorney in Las Vegas, said (1). “The bill includes many other changes that undoubtedly benefit the industry.”
MJBizDaily noted that SB 277 listed (1):
Nearly one third of the state’s 100 cannabis retailers will be able to benefit from the dual license.
Also included in the cannabis-related legislation (1):
With these laws, they will hopefully ease some of Nevada’s cannabis industry’s challenges.
“This is a recognition that the cannabis industry is a significant player in the state’s economy,” CCG Executive Director Tyler Klimas told MJBizDaily (1). “And we’re evolving appropriately.”
As these laws begin to take effect, Nevada’s cannabis industry players will definitely take advantage of these changes and benefits.
References
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.